Related Experiment Video
Updated: Dec 3, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Shared Genetics of Multiple System Atrophy and Inflammatory Bowel Disease
Alexey A Shadrin1, Sören Mucha2, David Ellinghaus2
1NORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Multiple system atrophy (MSA) shares genetic links with inflammatory bowel disease, suggesting immune and gut dysfunction may play a role in this rare neurodegenerative disease. The C7 gene is implicated in both conditions.
Area of Science:
- Neurogenetics
- Immunology
- Gastroenterology
Background:
- Multiple system atrophy (MSA) is a rare neurodegenerative disorder characterized by α-synuclein aggregation and neuronal loss.
- Emerging evidence suggests autoimmune mechanisms may contribute to MSA pathogenesis.
- The genetic basis for the potential interaction between MSA and autoimmune diseases remains largely unknown.
Purpose of the Study:
- To investigate the genetic overlap between MSA and seven autoimmune diseases.
- To identify shared genetic loci contributing to both MSA and autoimmune conditions.
Main Methods:
- Utilized genome-wide association study summary statistics for MSA and seven autoimmune diseases.
- Employed cross-trait conjunctional false discovery rate analysis to identify overlapping genetic regions.
- Examined candidate gene expression in transgenic MSA mice and analyzed genetic variability in independent patient cohorts.
Main Results:
- Identified significant polygenic overlap between MSA and inflammatory bowel disease (IBD).
- Discovered three shared genetic loci, including variants near DENND1B, RSP04, and within the C7 gene.
- Found dysregulated C7 gene expression in MSA mouse models and an increased burden of C7 variants in MSA and IBD patient cohorts.
Conclusions:
- Provided evidence for a shared genetic etiology between MSA and IBD.
- Highlighted the C7 gene as a key player in both MSA and IBD.
- Suggested that immune and gut dysfunction are implicated in the pathophysiology of MSA.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

